Idiopathic multicentric Castleman disease (iMCD)

iMCD can have damaging
effects on the body

Strike Back With SYLVANT
man-lymph-wall

Idiopathic multicentric Castleman disease (iMCD)

SYLVANT® (siltuximab) is the only FDA-approved treatment specifically indicated for iMCD

Learn More
campaign-woman-lymph-wall-2

Understanding
iMCD

Learn More

How SYLVANT
Can Help People
With iMCD

Learn More

Explore Our
Interactive
Discussion Guide

Visit Now

Co-pay Assistance
and Patient
Support

Learn More

Uncovering a Mystery:
Castleman Disease

Watch Video
The Balancing Act

Abbreviations: FDA, US Food and Drug Administration; iMCD, idiopathic multicentric Castleman disease.